focus -WSS

focus

author：focus 2025-09-27 12:21:42 - browse：654

Sanofi CEO Paul Hudson Courtesy Sanofi

NEW YORK — The top executives at French drug giant Sanofi on Wednesday defended their decision to reduce earnings forecasts for 2024 in order to fund more research studies of new medicines they say could one day generate billions of dollars in annual sales.

CEO Paul Hudson and Houman Ashrafian, Sanofi’s new head of R&D, made their remarks in an exclusive interview with STAT ahead of a full-day meeting with analysts here. When the cuts to earnings were first announced Oct. 27, along with a plan to spin off the company’s consumer products division, shares dove 18% and have yet to fully recover. The share price is down 5% since the beginning of 2023.

“I’ve been waiting four years for a situation where we could put [out] the pipeline, as impressive as it is, and declare that we’re going to be the world’s leading immunology company,” said Hudson, who took over as CEO in 2019. “So it’s quite an important moment for us. And it’s an important moment to declare that we’re back in science, because I could argue that we haven’t been where we needed to be.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Affirmative action in medical school literally saved lives
Next article： Weekend shootings leave at least 6 dead, 20 others wounded in Chicago

explore

WSS

FDA seeks to regulate lab

WHO recommends dropping component of many flu vaccines

Clinic falsely told dozens they had Alzheimer's, suits say

Mike Pence ‘not interested in trading insults’ with Trump as he tries to win New Hampshire

Health tech startups drop sharply from 2021 highs

Kaiser Permanente unions announce official strike date

knowledge

focus

focus

After affirmative action ruling, medical educators look to 'holistic review'

Transgender women dream of pregnancy via uterus transplants

Bright Health sells Medicare Advantage business to Molina

How to protect coverage of PrEP

Peter Hotez and the public health issue of online harassment

Cigna to pay $172 million to settle Medicare Advantage fraud probe

Tori Bowie and the unacceptable rates of Black maternal death

Thousands protest mob assault of women who were paraded naked in remote Indian border state

At least 13 dead in Texas as scorching temps continue

How to protect coverage of PrEP

Wikipedia

Burning questions about Delta and the next phase of the Covid pandemic

Woman found dead after suspected bear encounter near Yellowstone, wildlife officials say

Data show record exodus of life scientists from academia

Severe heat forecast: Where scorching temperatures will persist over the next week

PrEP can help anyone prevent HIV. Why do so few people take it?

How to protect coverage of PrEP

explore

hotspot

explore

explore